
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Share Price Rises 17.32% Today
Updated: 22 Oct 2026 • 10:58 am
Posted by:

Himalaya Nutravedics India Lim Share Price is trading higher today at Rs 144.95, up 17.32% from the previous close of Rs 123.55. The company’s market capitalisation stands at Rs 108.8 Cr, placing the move in a clear small-company context without changing the underlying business picture. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers tracking Himalaya Nutravedics India Lim Share Price Today, the key point is that the stock opened at Rs 118, touched a low of Rs 118 and reached a high of Rs 144.95 in the same session. That gives a precise read on today’s share price gain, which is relevant for anyone following Himalaya Nutravedics India Lim Stock News, share price rise and Himalaya Nutravedics India Lim Share Price Update. Investors can next monitor whether the same price action is matched by fresh business or valuation context in the broader market narrative around Univest.
Himalaya Nutravedics India Lim Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 144.95 |
| Previous Close | Rs 123.55 |
| Today's Move | Rs 21.4 (+17.32%) |
| Open | Rs 118 |
| High | Rs 144.95 |
| Low | Rs 118 |
| Market Capitalisation | Rs 108.8 crore |
| Market Cap Category | Micro Cap |
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) rose to Rs 144.95 from the previous close of Rs 123.55, a move of Rs 21.4 or 17.32%. The stock opened at Rs 118, reached a high of Rs 144.95, recorded a low of Rs 118.
Himalaya Nutravedics India Lim Share Price is showing a sharp intraday rise, with the stock moving from Rs 118 at the open to Rs 144.95 at the top of the range. That is a gain of Rs 21.40 over the previous close and a 17.32% share price rise today. The current price equals the day high, while the day low also stood at Rs 118, so the full range remains easy to read. For investors tracking Himalaya Nutravedics India Lim Share Price Live, this is a clean price action move rather than a story built on unsupported colour. The market cap at Rs 108.8 Cr also keeps the move visible in the context of Himalaya Nutravedics India Lim Stock Performance. The next layer of analysis is fundamental context, which helps explain whether the valuation backdrop supports the move in Univest coverage.
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 108.8 crore |
| P/E Ratio | 14.72x |
| P/B Ratio | 2.54x |
| EPS | Rs 8.39 |
| Book Value Per Share | Rs 48.69 |
| Dividend Yield | 0% |
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) fundamental metrics show P/E 14.72x, P/B 2.54x. These ratios show where the company stands today and are not a call to buy or sell.
HIMALAYA NUTRAVEDICS INDIA LIM has a market capitalisation of Rs 108.8 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 14.72x, P/B at 2.54x should be read against the sector and peer benchmarks rather than as a standalone signal. According to latest Univest data, additional metrics include EPS of Rs 8.39, book value per share of Rs 48.69, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.23x, median ROE of 11.33%, median ROCE of 13.25%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 14.72x |
| Benchmark Median P/E | 31.23x |
| Benchmark Average P/E | 45.39x |
| Benchmark P/E Range | 3.4x to 616.23x |
| Company P/B Ratio | 2.54x |
| Benchmark Median P/B | 2.71x |
| Benchmark Median ROE | 11.33% |
| Benchmark Median ROCE | 13.25% |
| Company Market Capitalisation | Rs 108.8 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 14.72x, which is below the benchmark median of 31.23x, a difference of -52.87%. A P/E difference of this kind is a reference point rather than a recommendation.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,310.94 | 83.04 | 13.75 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,73,078.79 | 78.96 | 19.19 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,433.99 | 99.43 | 19.28 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,022.18 | 24.7 | 4.13 | 19.69 | 21.39 |
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 14.72x compared with the displayed peer median of 78.96x. This is a relative valuation comparison, not a buy or sell signal. HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a market capitalisation of Rs 108.8 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Himalaya Nutravedics India Lim
- Himalaya Nutravedics India Lim Share Price is trading at Rs 144.95 after a 17.32% rise today.
- The stock’s previous close was Rs 123.55, and the day high matched the current price.
- Himalaya Nutravedics India Lim Share Price Today comes with a market capitalisation of Rs 108.8 Cr.
- The P/E of 14.72 sits below the same-industry median and average in Univest data.
- The P/B of 2.54 is close to the benchmark median of 2.71 and below the benchmark average of 4.05.
About Himalaya Nutravedics India Lim
Himalaya Nutravedics India Lim operates in the Healthcare sector and the Pharmaceuticals & Drugs industry.Himalaya Nutravedics India Lim Share Price therefore belongs to a small-company profile within a large industry universe, where benchmark companies range from much smaller listed names to very large pharmaceutical businesses. In practical terms, investors following Himalaya Nutravedics India Lim Stock News are likely to focus on price behaviour, valuation and any future business disclosure that can be directly tied to the company. For now, the available profile supports a straightforward reading: a listed healthcare company with a low absolute market cap, a moderate P/E and a P/B near the industry median, all of which matter for Himalaya Nutravedics India Lim Share Price analysis on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Himalaya Nutravedics India Lim Share Price rising today?
Ans. Himalaya Nutravedics India Lim Share Price is rising today because the stock is trading at Rs 144.95, up 17.32% from Rs 123.55. The price move is confirmed in Univest data; a company-specific reason has not been established.
What is Himalaya Nutravedics India Lim Share Price today?
Ans. Himalaya Nutravedics India Lim Share Price today is Rs 144.95. The stock opened at Rs 118 and touched the same level as the day high, which makes today’s move easy to read from the price range.
How much did Himalaya Nutravedics India Lim Share Price gain today?
Ans. Himalaya Nutravedics India Lim Share Price gained Rs 21.40 today, which works out to 17.32%. The previous close was Rs 123.55, so the move is significant in percentage and absolute terms.
What is the market capitalisation of Himalaya Nutravedics India Lim?
Ans. Himalaya Nutravedics India Lim has a market capitalisation of Rs 108.8 Cr. That places the company in a smaller market-cap context within the Healthcare sector and helps frame its Share Price movement.
What do Himalaya Nutravedics India Lim valuation ratios show?
Ans. Himalaya Nutravedics India Lim Share Price is supported by a P/E of 14.72 and a P/B of 2.54. EPS is Rs 8.39 and book value is Rs 48.69, which gives investors a clearer valuation reference.
How does Himalaya Nutravedics India Lim compare with peers?
Ans. Himalaya Nutravedics India Lim Share Price is lower in market cap than the major listed peers shown, and its P/E is also below the peer set. Its P/B is near the lower end of the group and close to Dr. Reddy’s Laboratories.
Which sector does Himalaya Nutravedics India Lim belong to?
Ans. Himalaya Nutravedics India Lim belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The same-industry benchmark in Univest data covers 199 companies, giving useful context for Himalaya Nutravedics India Lim Share Price.
Does Himalaya Nutravedics India Lim pay a dividend yield?
Ans. Himalaya Nutravedics India Lim has a dividend yield of 0% in the current profile. That means the present valuation discussion around Himalaya Nutravedics India Lim Share Price is driven more by price, earnings and book value than by yield.
Track Himalaya Nutravedics India Lim Share Price on Univest
Use HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Himalaya Nutravedics India Lim Share Price on Univest for live updates, valuation ratios, market capitalisation, 52-week levels and company insights. Univest brings together Himalaya Nutravedics India Lim Share Price Today, stock analysis and market context in one place so readers can follow the latest move with clarity.
Recent Articles

Gokaldas Exports Shares in Focus: Gokaldas Exports Q2 Results, the 5% Move in Five Days, the Exchange Filings and What Is Unverified
10 November 2026

FPI Inflows Hit Rs 53,739 Crore in November 2026 as FPIs Return to Indian Stocks: Reasons, Data Gaps and the Risks of a Reversal
10 November 2026

US Stocks Inflows of $2.1 Trillion: What the Wall Street Fund-Flow Figure Measures, What It Does Not, and Why the Numbers Differ by Source
10 November 2026

NSE New Headquarters Design Unveiled: The Plot, the Architect and What the NSE BKC Move Means for the Exchange and Investors
10 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gokaldas Exports Shares in Focus: Gokaldas Exports Q2 Results, the 5% Move in Five Days, the Exchange Filings and What Is Unverified
FPI Inflows Hit Rs 53,739 Crore in November 2026 as FPIs Return to Indian Stocks: Reasons, Data Gaps and the Risks of a Reversal
US Stocks Inflows of $2.1 Trillion: What the Wall Street Fund-Flow Figure Measures, What It Does Not, and Why the Numbers Differ by Source
NSE New Headquarters Design Unveiled: The Plot, the Architect and What the NSE BKC Move Means for the Exchange and Investors
MRF Dividend 2026: India's Most Expensive Stock Declares a Rs 3 Payout, and What It Means for the MRF Share Price and Shareholders

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





